DrugPatentWatch Database Preview➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing
« Back to Dashboard
Pafuramidine is an investigational drug.
There have been 4 clinical trials for Pafuramidine. The most recent clinical trial was a Phase 2 trial, which was initiated on May 1st 2006.
The most common disease conditions in clinical trials are Trypanosomiasis, African, Trypanosomiasis, and Lung Diseases, Interstitial. The leading clinical trial sponsors are Immtech Pharmaceuticals, Inc, Bill and Melinda Gates Foundation, and [disabled in preview].
Recent Clinical Trials for Pafuramidine
|Randomized, Double-Blind Phase 1 Safety and Tolerability Study of Pafuramidine Maleate (DB289) in Healthy Subjects||Immtech Pharmaceuticals, Inc||Phase 1|
|DB289 Versus TMP-SMX for the Treatment of Acute Pneumocystis Jiroveci Pneumonia (PCP)||Immtech Pharmaceuticals, Inc||Phase 3|
|Trial of DB289 for the Treatment of Stage I African Trypanosomiasis||Bill and Melinda Gates Foundation||Phase 2|